Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of melatonin vs low-dose quetiapine vs placebo in psychiatric patients with comorbid insomnia
2023-504728-24-00Phase 3Authorised
- Sponsor
- Capital Region of Denmark
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Insomnia and mental disorder comparing Melatonin, Low-dose quetiapine and Placebo (3 arms). Primary endpoint: Insomnia Severity Index (ISI). Planned start Jul 2023; status: authorised.
02
Drugs
melatoninquetiapine
03
Conditions
Insomniamental disorder
Beyond the preview
Go deeper on 2023-504728-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504728-24-00.